期刊文献+

六味消白方治疗白癜风疗效观察及机制研究 被引量:1

Study on Mechanism and Clinlical efficacy of the Six-flavor-eradicating vititligo prescription in Patients with Vitiligo
下载PDF
导出
摘要 目的:观察六味消白方治疗白癜风的临床疗效并探讨其作用机制。方法:将63例白癜风患者随机分为治疗组和对照组,两组疗程均为3个月。同时采用双抗体夹心ELISA法测定两组患者治疗前后血清IL-18、IL-17的水平。结果:治疗组有效率为84.37%,痊愈率为37.50%,对照组有效率为51.61%,痊愈率为19.35%,两组比较有显著性差异(P<0.05)。治疗组血清IL-18、IL-17的水平治疗前较治疗后两者有显著性差异,对照组治疗前后血清中两者水平差异无显著性。结论:六味消白方治疗白癜风安全有效。六味消白方治疗白癜风可能通过抑制IL-18、IL-17而起治疗作用。 Objective:To investigate the mechanism and Clinlical efficacy of the Six-flavor- eradicating vititligo prescription in patients with vitiligo.Methods:63 vitiligo patients were randomly divided into two groups: 32 cases in experimental group and 31 cases in control group. The period of treatment in two group were 3 months. Enzyme-linked immunosorbent assy (ELISA) were used to detect the serum levels of IL-18 and IL-17 in two groups before and after treatment.Results:The effective rates of two groups were separately 84.37 % and 51.61% , and the healing rates of two groups were separately 37.50% and 19.35% ,there was significant difference between the two groups (P〈O.05). The serum level of IL-18 and IL-17 in the experimental group was signifcanfly difference before and after treatment (P〈0.05), while there is no significant difference between the indicators before and after treatment of the control group. Conclusion: Six-flavor- eradicating vititligo prescription is effective and well-tolerated in the treatment of vitiligo. The treatment effects of Six-flavor- eradicating vititligo prescription may he through its inhibiting effects on IL-18 and IL-17.
出处 《北方药学》 2013年第11期21-23,共3页 Journal of North Pharmacy
关键词 白癜风 六味消白方 白细胞介素10白细胞介素17 Vitiligo Six-flavor-eradicating vititligo prescription Intedeukin-18 Interleukin-17
  • 相关文献

参考文献5

二级参考文献17

  • 1GU Y, YANG J, OUYANG X, et al. Interleukin 10 suppresses Thl7 cytokines secreted by macrophages and T cells [ J ]. Eur J Immunol,2008,38(7) : 1807-1813.
  • 2COURY F, ANNELS N, RIVOLLIER A, et al. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion[J]. Nat Med,2008,14(1) :81-87.
  • 3SHEN F, GAFFEN S L. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy[J]. Cytokine,2008,41 (2) :92-104.
  • 4RUDDY M J, WONG G C, LIU X K, et al. Functional cooperation between interleukin- 17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer binding protein family members[ J]. J Biol Chem,2004,279 (4) :2559-2567.
  • 5SHEN F, H U Z, GOSWAMI J, et al. Identification of common transcriptional regulatory elements in interleukin-17 target genes[ J ]. J Biol Chem, 2006,281 (34) :24138 -24148.
  • 6RONG Z, CHENG L, REN Y, et al. Interleukin-17F signaling requires ubiquitination of interleukin-17 receptor via TRAF6 [ J ]. Cell Signal,2007,19 (7) :1514-1520.
  • 7QIAN Y, LIU C, HARTUPEE J, et al. Actl is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease[J]. Nat Immunol,2007, 8 (3) :247-256.
  • 8MAITRA A, SHEN F, HANEL W, et al. Distinct functional motifs within the 1L-17 receptor regulate signal transduction and target gene expression [ J ]. Proc Natl Acad Sci USA,2007,104(18) :7506-7511.
  • 9ORIHARA K, NAKAE S, PAWANKAR R, et al. Role of regulatory and pminflammatory T- cell populations in allergic diseases[J]. World Allergy Organization Journal,2008,1 (1) :9-14.
  • 10WONG C K, LIT L C, TAM L S, et al. Hyperproduction of I-L23 and IL-17 in patients with systemic lupus erythematosus:implications for Th17-mediated inflammation in auto-immunity [ J ]. Clin Immunol, 2008,127 (3) :385-393.

共引文献132

同被引文献10

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部